Boothbay Fund Management’s Array Biopharma Inc ARRY Stock Holding History

Boothbay Fund Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-577	Closed	-$2.67M	–	1006
2019 Q2	$2.67M	Buy	577 +376	+187%	+$10.6K	0.24%	100
2019 Q1	$490K	Buy	+201	New	+$4.18K	0.05%	387
2018 Q1	–	Sell	-243	Closed	-$311K	–	967
2017 Q4	$311K	Buy	+243	New	+$2.76K	0.05%	416

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Boothbay Fund Management's ARRY Position: Q3 2019 in Review

Boothbay Fund Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 119,526 shares — an estimated $5.54M sold.

Boothbay Fund Management first reported a position in ARRY in Q3 2016 and held it in 2 quarters. The position peaked at $5.54M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Boothbay Fund Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Boothbay Fund Management sold 119,526 Array Biopharma Inc shares in Q3 2019, an estimated $5.54M.
Boothbay Fund Management first reported a position in Array Biopharma Inc in Q3 2016 and held it in 2 quarters.
Boothbay Fund Management's Array Biopharma Inc position peaked at $5.54M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Boothbay Fund Management's 13F filing for Q3 2019, filed 14 Nov 2019.